Clinical Trial Update: Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 study from Stanford evaluated a haploidentical hematopoietic cell transplantation approach using a T-cell depleted graft with simultaneous…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma

Snippet

Sponsor: Stanford University | Conditions: Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-08-19